Search by Drug Name or NDC
NDC 68547-0501-02 Giapreza 2.5 mg/mL Details
Giapreza 2.5 mg/mL
Giapreza is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by La Jolla Pharmaceutical Company. The primary component is ANGIOTENSIN II.
Product Information
| NDC | 68547-0501 |
|---|---|
| Product ID | 68547-501_efe1c60f-f03b-c3d7-e053-2a95a90a7dd5 |
| Associated GPIs | 38000007102020 |
| GCN Sequence Number | 078059 |
| GCN Sequence Number Description | angiotensin II acetate, human VIAL 2.5 MG/ML INTRAVEN |
| HIC3 | P7B |
| HIC3 Description | RENIN-ANGIOTENSIN-ALDOSTERONE SYS. (RAAS) HORMONES |
| GCN | 44297 |
| HICL Sequence Number | 044721 |
| HICL Sequence Number Description | ANGIOTENSIN II ACETATE, HUMAN |
| Brand/Generic | Brand |
| Proprietary Name | Giapreza |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | angiotensin II |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 2.5 |
| Active Ingredient Units | mg/mL |
| Substance Name | ANGIOTENSIN II |
| Labeler Name | La Jolla Pharmaceutical Company |
| Pharmaceutical Class | Vasoconstriction [PE], Vasoconstrictor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA209360 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68547-0501-02 (68547050102)
| NDC Package Code | 68547-501-02 |
|---|---|
| Billing NDC | 68547050102 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (68547-501-02) / 1 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2018-02-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |